Ma et al. investigated the effect of RBM3 on nasopharyngeal carcinoma cell radioresistance and found that it activates the survival PI3K/AKT signaling pathway, regulates Bcl-2, and inhibits caspase 3, enabling cancer cell survival through apoptosis evasion and increasing resistance to RT [33]. Here, BCL2 is linked to cancer.